These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 32994446)

  • 1. Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages.
    Heinrich ML; Boisen ML; Nelson DKS; Bush DJ; Cross RW; Koval AP; Hoffmann AR; Beddingfield BJ; Hastie KM; Rowland MM; Aimukanova I; Koval S; Lathigra R; Borisevich V; Momoh M; Sandi JD; Goba A; Odia L; Baimba F; Aiyepada JO; Ebo B; Eromon P; Ugwu C; Folarin O; Olumade T; Onyechi MN; Etafo J; Adeyemi R; Ella EE; Aminu M; Gomerep SS; Eke MA; Ogunsanya O; Akpede GO; Asogun DO; Okogbenin SA; Okokhere PO; Holst J; Shaffer JG; Schieffelin JS; Geisbert TW; Saphire EO; Happi CT; Grant DS; Garry RF; Branco LM
    Sci Rep; 2020 Sep; 10(1):16030. PubMed ID: 32994446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Common CD8
    Sakabe S; Hartnett JN; Ngo N; Goba A; Momoh M; Sandi JD; Kanneh L; Cubitt B; Garcia SD; Ware BC; Kotliar D; Robles-Sikisaka R; Gangavarapu K; Branco LM; Eromon P; Odia I; Ogbaini-Emovon E; Folarin O; Okogbenin S; Okokhere PO; Happi C; Sabeti PC; Andersen KG; Garry RF; de la Torre JC; Grant DS; Schieffelin JS; Oldstone MBA; Sullivan BM
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report.
    Branco LM; Boisen ML; Andersen KG; Grove JN; Moses LM; Muncy IJ; Henderson LA; Schieffellin JS; Robinson JE; Bangura JJ; Grant DS; Raabe VN; Fonnie M; Zaitsev EM; Sabeti PC; Garry RF
    Virol J; 2011 Aug; 8():404. PubMed ID: 21843352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection.
    Branco LM; Grove JN; Boisen ML; Shaffer JG; Goba A; Fullah M; Momoh M; Grant DS; Garry RF
    Virol J; 2011 Oct; 8():478. PubMed ID: 22023795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak.
    Boisen ML; Uyigue E; Aiyepada J; Siddle KJ; Oestereich L; Nelson DKS; Bush DJ; Rowland MM; Heinrich ML; Eromon P; Kayode AT; Odia I; Adomeh DI; Muoebonam EB; Akhilomen P; Okonofua G; Osiemi B; Omoregie O; Airende M; Agbukor J; Ehikhametalor S; Aire CO; Duraffour S; Pahlmann M; Böhm W; Barnes KG; Mehta S; Momoh M; Sandi JD; Goba A; Folarin OA; Ogbaini-Emovan E; Asogun DA; Tobin EA; Akpede GO; Okogbenin SA; Okokhere PO; Grant DS; Schieffelin JS; Sabeti PC; Günther S; Happi CT; Branco LM; Garry RF
    Sci Rep; 2020 May; 10(1):8724. PubMed ID: 32457420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.
    Safronetz D; Mire C; Rosenke K; Feldmann F; Haddock E; Geisbert T; Feldmann H
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003736. PubMed ID: 25884628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins.
    Wang M; Jokinen J; Tretyakova I; Pushko P; Lukashevich IS
    Vaccine; 2018 Jan; 36(5):683-690. PubMed ID: 29287681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever.
    Boisen ML; Hartnett JN; Shaffer JG; Goba A; Momoh M; Sandi JD; Fullah M; Nelson DKS; Bush DJ; Rowland MM; Heinrich ML; Koval AP; Cross RW; Barnes KG; Lachenauer AE; Lin AE; Nekoui M; Kotliar D; Winnicki SM; Siddle KJ; Gbakie M; Fonnie M; Koroma VJ; Kanneh L; Kulakosky PC; Hastie KM; Wilson RB; Andersen KG; Folarin OO; Happi CT; Sabeti PC; Geisbert TW; Saphire EO; Khan SH; Grant DS; Schieffelin JS; Branco LM; Garry RF
    Sci Rep; 2018 Apr; 8(1):5939. PubMed ID: 29651117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever.
    Branco LM; Grove JN; Geske FJ; Boisen ML; Muncy IJ; Magliato SA; Henderson LA; Schoepp RJ; Cashman KA; Hensley LE; Garry RF
    Virol J; 2010 Oct; 7():279. PubMed ID: 20961433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence variability and geographic distribution of Lassa virus, Sierra Leone.
    Leski TA; Stockelman MG; Moses LM; Park M; Stenger DA; Ansumana R; Bausch DG; Lin B
    Emerg Infect Dis; 2015 Apr; 21(4):609-18. PubMed ID: 25811712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High crossreactivity of human T cell responses between Lassa virus lineages.
    Sullivan BM; Sakabe S; Hartnett JN; Ngo N; Goba A; Momoh M; Demby Sandi J; Kanneh L; Cubitt B; Garcia SD; Ware BC; Kotliar D; Robles-Sikisaka R; Gangavarapu K; Branco L; Eromon P; Odia I; Ogbaini-Emovon E; Folarin O; Okogbenin S; Okokhere PO; Happi C; de la Torre JC; Sabeti PC; Andersen KG; Garry RF; Grant DS; Schieffelin JS; Oldstone MBA
    PLoS Pathog; 2020 Mar; 16(3):e1008352. PubMed ID: 32142546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and cellular immune responses to Lassa fever virus in Lassa fever survivors and their exposed contacts in Southern Nigeria.
    Ugwu C; Olumade T; Nwakpakpa E; Onyia V; Odeh E; Duruiheoma RO; Ojide CK; Eke MA; Nwafor IE; Chika-Igwenyi N; Abu AM; Azuogu B; Ajayi N; Ogah E; Ayodeji O; Abejegah C; Adedosu N; Oyejide N; Abah S; Omidele A; Ingbian W; Osoba E; Eromon P; Oluniyi P; Ogunsanya O; Happi A; Otuh P; Nadesalingam A; Carnell G; Krause N; Aguinam E; Kinsley R; Storisteanu DML; Tonks P; Nelson D; McAlister C; Boisen M; Garry R; Wright E; Temperton N; Frost S; Heeney JL; Happi C
    Sci Rep; 2022 Dec; 12(1):22330. PubMed ID: 36567369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2
    Wauquier N; Petitdemange C; Tarantino N; Maucourant C; Coomber M; Lungay V; Bangura J; Debré P; Vieillard V
    EBioMedicine; 2019 Feb; 40():605-613. PubMed ID: 30711514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An mRNA-LNP-based Lassa virus vaccine induces protective immunity in mice.
    Hashizume M; Takashima A; Iwasaki M
    J Virol; 2024 Jun; 98(6):e0057824. PubMed ID: 38767352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undiagnosed acute viral febrile illnesses, Sierra Leone.
    Schoepp RJ; Rossi CA; Khan SH; Goba A; Fair JN
    Emerg Infect Dis; 2014 Jul; 20(7):1176-82. PubMed ID: 24959946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lassa fever in post-conflict sierra leone.
    Shaffer JG; Grant DS; Schieffelin JS; Boisen ML; Goba A; Hartnett JN; Levy DC; Yenni RE; Moses LM; Fullah M; Momoh M; Fonnie M; Fonnie R; Kanneh L; Koroma VJ; Kargbo K; Ottomassathien D; Muncy IJ; Jones AB; Illick MM; Kulakosky PC; Haislip AM; Bishop CM; Elliot DH; Brown BL; Zhu H; Hastie KM; Andersen KG; Gire SK; Tabrizi S; Tariyal R; Stremlau M; Matschiner A; Sampey DB; Spence JS; Cross RW; Geisbert JB; Folarin OA; Happi CT; Pitts KR; Geske FJ; Geisbert TW; Saphire EO; Robinson JE; Wilson RB; Sabeti PC; Henderson LA; Khan SH; Bausch DG; Branco LM; Garry RF;
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2748. PubMed ID: 24651047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current research for a vaccine against Lassa hemorrhagic fever virus.
    Warner BM; Safronetz D; Stein DR
    Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues.
    Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.
    Maruyama J; Mateer EJ; Manning JT; Sattler R; Seregin AV; Bukreyeva N; Jones FR; Balint JP; Gabitzsch ES; Huang C; Paessler S
    Vaccine; 2019 Oct; 37(45):6824-6831. PubMed ID: 31561999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive genetic diversification of Lassa virus associated with the epidemic split of north-central Nigerian and non-Nigerian lineages.
    Li Y; Tian H
    Virology; 2020 Jun; 545():10-15. PubMed ID: 32174454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.